DOCSLIB.ORG

Table S3. RAE Analysis of Well-Differentiated Liposarcoma

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Table S3. RAE Analysis of Well-Differentiated Liposarcoma Table S3. RAE analysis of well-differentiated liposarcoma Model Chromosome Region start Region end Size q value freqX0* # genes Genes Amp 1 145009467 145122002 112536 0.097 21.8 2 PRKAB2,PDIA3P Amp 1 145224467 146188434 963968 0.029 23.6 10 CHD1L,BCL9,ACP6,GJA5,GJA8,GPR89B,GPR89C,PDZK1P1,RP11-94I2.2,NBPF11 Amp 1 147475854 148412469 936616 0.034 23.6 20 PPIAL4A,FCGR1A,HIST2H2BF,HIST2H3D,HIST2H2AA4,HIST2H2AA3,HIST2H3A,HIST2H3C,HIST2H4B,HIST2H4A,HIST2H2BE, HIST2H2AC,HIST2H2AB,BOLA1,SV2A,SF3B4,MTMR11,OTUD7B,VPS45,PLEKHO1 Amp 1 148582896 153398462 4815567 1.5E-05 49.1 152 PRPF3,RPRD2,TARS2,ECM1,ADAMTSL4,MCL1,ENSA,GOLPH3L,HORMAD1,CTSS,CTSK,ARNT,SETDB1,LASS2,ANXA9, FAM63A,PRUNE,BNIPL,C1orf56,CDC42SE1,MLLT11,GABPB2,SEMA6C,TNFAIP8L2,LYSMD1,SCNM1,TMOD4,VPS72, PIP5K1A,PSMD4,ZNF687,PI4KB,RFX5,SELENBP1,PSMB4,POGZ,CGN,TUFT1,SNX27,TNRC4,MRPL9,OAZ3,TDRKH,LINGO4, RORC,THEM5,THEM4,S100A10,S100A11,TCHHL1,TCHH,RPTN,HRNR,FLG,FLG2,CRNN,LCE5A,CRCT1,LCE3E,LCE3D,LCE3C,LCE3B, LCE3A,LCE2D,LCE2C,LCE2B,LCE2A,LCE4A,KPRP,LCE1F,LCE1E,LCE1D,LCE1C,LCE1B,LCE1A,SMCP,IVL,SPRR4,SPRR1A,SPRR3, SPRR1B,SPRR2D,SPRR2A,SPRR2B,SPRR2E,SPRR2F,SPRR2C,SPRR2G,LELP1,LOR,PGLYRP3,PGLYRP4,S100A9,S100A12,S100A8, S100A7A,S100A7L2,S100A7,S100A6,S100A5,S100A4,S100A3,S100A2,S100A16,S100A14,S100A13,S100A1,C1orf77,SNAPIN,ILF2, NPR1,INTS3,SLC27A3,GATAD2B,DENND4B,CRTC2,SLC39A1,CREB3L4,JTB,RAB13,RPS27,NUP210L,TPM3,C1orf189,C1orf43,UBAP2L,HAX1, AQP10,ATP8B2,IL6R,SHE,TDRD10,UBE2Q1,CHRNB2,ADAR,KCNN3,PMVK,PBXIP1,PYGO2,SHC1,CKS1B,FLAD1,LENEP,ZBTB7B,DCST2, DCST1,ADAM15,EFNA4,EFNA3,EFNA1,RAG1AP1,DPM3 Amp 1 153700678 153894854 194177 0.027 25.5 2 ASH1L,MSTO1 Amp 1 154108857 154183585 74729 0.016 25.5 7 SYT11,RIT1,KIAA0907,SNORA42,SCARNA4,RXFP4,ARHGEF2 Amp 1 155214884 155356571 141688 0.040 23.6 2 ARHGEF11,ETV3L Amp 1 155520004 155720600 200597 0.040 25.5 0 [Nearest:FCRL5] Amp 1 156067709 164154281 8086573 1.9E-06 43.6 120 CD5L,KIRREL,CD1D,CD1A,CD1C,CD1B,CD1E,OR10T2,OR10K2,OR10K1,OR10R2,OR6Y1,OR10X1,OR10Z1,SPTA1,OR6K2,OR6K3,OR6K6, OR6N1,OR6N2,MNDA,PYHIN1,IFI16,AIM2,CADM3,DARC,FCER1A,OR10J3,OR10J1,OR10J5,APCS,CRP,DUSP23,FCRL6,SLAMF8,VSIG8, CCDC19,TAGLN2,IGSF9,SLAMF9,PIGM,KCNJ10,KCNJ9,IGSF8,ATP1A2,ATP1A4,CASQ1,PEA15,WDR42A,PEX19,COPA,SUMO1P3,NCSTN, NHLH1,VANGL2,SLAMF6,CD84,SLAMF1,CD48,SLAMF7,LY9,CD244,ITLN1,ITLN2,F11R,RP11- 544M22.4,USF1,ARHGAP30,PVRL4,KLHDC9,PFDN2,NIT1,DEDD,UFC1,USP21,PPOX,B4GALT3,ADAMTS4,NDUFS2,FCER1G,APOA2,TOMM40L,N R1I3,PCP4L1,MPZ,SDHC,hCG_1776980,C1orf192,FCGR2A,HSPA6,FCGR3A,FCGR2C,FCGR3B,FCGR2B,RPL31P11,FCRLA,FCRLB,DUSP12,ATF6,OL FML2B,NOS1AP,C1orf111,C1orf226,SH2D1B,UHMK1,UAP1,DDR2,HSD17B7,C1orf110,RGS4,RGS5,NUF2,PBX1,LMX1A,RXRG,LRRC52,MGST3,A LDH9A1,TMCO1,UCK2 Amp 1 164857764 165399992 542229 0.026 25.5 7 FMO9P,POGK,TADA1L,ILDR2,MAEL,GPA33,DUSP27 Amp 1 167007682 171482622 4474941 1.6E-07 36.4 33 ATP1B1,NME7,BLZF1,C1orf114,SLC19A2,F5,SELP,SELL,SELE,C1orf156,C1orf112,SCYL3,KIFAP3,GORAB,PRRX1,C1orf129,FMO3,FMO6P,FMO2, FMO1,FMO4,TOP1P1,BAT2D1,MYOC,VAMP4,METTL13,DNM3,C1orf105,PIGC,C1orf9,FASLG,TNFSF18,TNFSF4 Amp 1 171812441 172242030 429590 0.0086 27.3 14 SLC9A11,ANKRD45,KLHL20,CENPL,DARS2,GAS5,SNORD47,SNORD80,SNORD78,SNORD76,SNORD74,ZBTB37,SERPINC1,RC3H1 Amp 1 172326170 172454962 128793 0.049 21.8 1 RABGAP1L Amp 1 172571475 172688677 117203 0.047 21.8 2 RABGAP1L,GPR52 Amp 1 172729145 173129536 400392 0.015 25.5 1 RABGAP1L Amp 1 173246578 173270799 24222 0.039 21.8 2 CACYBP,MRPS14 Amp 1 173442996 174176595 733600 0.0050 25.5 1 TNR Amp 1 174610694 174683039 72346 0.098 20 0 [Nearest:PAPPA2] Amp 1 176189757 176257679 67923 0.037 23.6 1 SEC16B Amp 1 176700160 177016348 316189 0.082 23.6 4 RASAL2,C1orf49,C1orf220,RALGPS2 Del 1 184303737 184407743 104007 0.018 9.1 1 HMCN1 Del 1 196061571 199158666 3097096 0.011 9.1 13 C1orf53,LHX9,NEK7,ATP6V1G3,PTPRC,NR5A2,FAM58B,ZNF281,KIF14,DDX59,CAMSAP1L1,GPR25,C1orf106 Del 1 199873365 200405230 531866 0.051 9.1 11 NAV1,IPO9,SHISA4,LMOD1,TIMM17A,RNPEP,ELF3,GPR37L1,ARL8A,PTPN7,PTPRV Del 1 201044387 201189356 144970 0.021 10.9 4 LOC148709,RABIF,KLHL12,ADIPOR1 Del 1 201426970 205657885 4230916 8.3E-05 14.5 62 CHIT1,BTG2,FMOD,PRELP,OPTC,ATP2B4,SNORA77,LAX1,ZC3H11A,SNRPE,C1orf157,SOX13,ETNK2,REN,KISS1,GOLT1A,PLEKHA6, PPP1R15B,PIK3C2B,MDM4,LRRN2,NFASC,CNTN2,TMEM81,RBBP5,DSTYK,TMCC2,NUAK2,KLHDC8A,LEMD1,PCTK3,MFSD4,ELK4, SLC45A3,NUCKS1,RAB7L1,SLC41A1,PM20D1,SLC26A9,FAM72A,AVPR1B,C1orf186,CTSE,SRGAP2,IKBKE,RASSF5,LGTN,DYRK3, MAPKAPK2,IL10,IL19,IL20,IL24,FAIM3,PIGR,FCAMR,C1orf116,YOD1,PFKFB2,C4BPB,C4BPA,CD55 Del 1 205858189 209222078 3363890 0.021 10.9 18 CR1,CR1L,CD46,CD34,PLXNA2,LOC642587,CAMK1G,LAMB3,G0S2,HSD11B1,TRAF3IP3,C1orf74,IRF6,C1orf107,SYT14,SERTAD4, HHAT,KCNH1 Del 1 209572983 209637355 64373 0.021 10.9 1 TRAF5 Del 1 210865589 214238939 3373351 0.018 9.1 16 FAM71A,BATF3,NSL1,TATDN3,C1orf227,FLVCR1,VASH2,ANGEL2,RPS6KC1,PROX1,SMYD2,PTPN14,CENPF,KCNK2,KCTD3,USH2A Del 1 214325747 214853588 527842 0.048 9.1 2 USH2A,ESRRG Del 1 214991000 215614604 623605 0.052 9.1 1 ESRRG Del 1 215685071 224858883 9173813 0.017 9.1 52 GPATCH2,SPATA17,RRP15,TGFB2,LYPLAL1,SLC30A10,EPRS,BPNT1,IARS2,RAB3GAP2,AURKAPS1,MARK1,C1orf115,MOSC2,MOSC1, HLX,DUSP10, HHIPL2,TAF1A,MIA3,AIDA,C1orf58,FAM177B,DISP1,TLR5,SUSD4,C1orf65,CAPN2,TP53BP2,FBXO28, DEGS1,NVL,CNIH4,WDR26,CNIH3,DNAH14,LBR,ENAH,SRP9,EPHX1,TMEM63A,LEFTY1,PYCR2,LEFTY2,C1orf55,H3F3A, LOC440926,ACBD3,MIXL1,LIN9,PARP1,C1orf95 Del 1 224904583 225768637 864055 0.0062 9.1 4 ITPKB,PSEN2,CABC1,CDC42BPA Del 1 225979138 234424821 8445684 0.00010 12.7 66 JMJD4,SNAP47,MPN2,WNT9A,WNT3A,ARF1,C1orf35,MRPL55,GUK1,GJC2,C1orf69,OBSCN,TRIM11,TRIM17,HIST3H3,HIST3H2A, HIST3H2BB,DUSP5P,RHOU,RAB4A,SPHAR,C1orf96,ACTA1,NUP133,ABCB10,TAF5L,URB2,GALNT2,PGBD5,COG2,AGT,CAPN9, C1orf198,TTC13,ARV1,FAM89A,TRIM67,C1orf131,GNPAT,EXOC8,C1orf124,EGLN1,TSNAX,DISC1,DISC2,SIPA1L2,KIAA1383,C1orf57, PCNXL2,KIAA1804,KCNK1,SLC35F3,C1orf31,TARBP1,IRF2BP2,TOMM20,SNORA14B,RBM34,ARID4B,GGPS1,TBCE,B3GALNT2, GNG4,LYST,NID1,GPR137B Del 1 238117512 238361689 244178 0.021 9.1 2 CHRM3,FMN2 Del 1 238441116 238783361 342246 0.021 9.1 2 FMN2,GREM2 Del 1 238967345 239083421 116077 0.021 9.1 1 RGS7 Del 1 239360147 239492605 132459 0.021 9.1 1 RGS7 Del 1 240054897 240104800 49904 0.020 9.1 1 EXO1 Del 1 241442091 241560407 118317 0.022 9.1 2 CEP170,SDCCAG8 Del 1 242692737 243906301 1213565 0.021 9.1 6 C1orf101,PPPDE1,FAM36A,HNRNPU,EFCAB2,KIF26B Del 1 246862029 247185356 323328 2.6E-08 18.2 8 OR2T35,OR2T27,OR14I1,LOC646627,SH3BP5L,ZNF672,ZNF692,PGBD2 Del 4 21911407 22194542 283136 0.078 9.1 1 GPR125 Amp 7 141985598 142192030 206433 0.0011 25.5 3 PRSS1,TRY6,PRSS2 Del 8 146024157 146264846 240690 0.00015 12.7 6 ZNF7,COMMD5,ZNF250,ZNF16,TMED10P,C8orf33 Del 9 194193 256045 61853 0.00015 5.5 2 C9orf66,DOCK8 Del 10 135124875 135271770 146896 0.0033 1.8 3 LOC619207,CYP2E1,SYCE1 Del 11 200300 1844960 1644661 0.00046 12.7 59 RIC8A,SIRT3,PSMD13,NLRP6,ATHL1,IFITM5,IFITM2,IFITM1,IFITM3,B4GALNT4,PKP3,SIGIRR,ANO9,PTDSS2,RNH1,HRAS,LRRC56, C11orf35,RASSF7,PHRF1,IRF7,MUPCDH,SCT,DRD4,DEAF1,TMEM80,EPS8L2,TALDO1,PDDC1,CEND1,SLC25A22,LRDD,RPLP2, SNORA52,PNPLA2,EFCAB4A,CD151,POLR2L,TSPAN4,CHID1,AP2A2,MUC6,MUC2,MUC5B,TOLLIP,BRSK2,HCCA2,DUSP8, LOC338651,KRTAP5-1,KRTAP5-2,KRTAP5-3,KRTAP5-4,KRTAP5-5,KRTAP5-6,CTSD,SYT8,TNNI2,LSP1 Del 11 3585368 6105831 2520464 0.0080 41.8 77 TRPC2,ART5,ART1,CHRNA10,NUP98,FRAG1,RHOG,STIM1,RRM1,OR52B4,TRIM21,OR52K2,OR52K1,OR52M1,C11orf40,OR52I2, OR52I1,TRIM68,OR51D1,OR51E1,OR51E2,OR51F1,OR52R1,OR51F2,OR51S1,OR51T1,OR51A7,OR51G2,OR51G1,OR51A4,OR51A2, MMP26,OR51L1,OR52J3,OR52E2,OR52A4,OR52A5,OR52A1,OR51V1,HBB,HBD,HBBP1,HBG1,HBG2,HBE1,OR51B4,OR51B2, OR51B5,OR51B6,OR51M1,OR51Q1,OR51I1,OR51I2,OR52D1,UBQLN3,UBQLNL,OR52H1,OR52B6,TRIM6,TRIM6- TRIM34,TRIM34,TRIMP1,TRIM5,TRIM22,OR56B1,OR52N4,OR52N5,OR52N1,OR52N2,OR52E6,OR52E8,OR52E4,OR56A3,OR52L1,OR56A4,OR 56A1,OR56B4 Del 11 21080944 35610142 14529199 2.5E-05 18.2 55 NELL1,ANO5,SLC17A6,FANCF,GAS2,SVIP,LUZP2,ANO3,MUC15,SLC5A12,FIBIN,BBOX1,CCDC34,LGR4,LIN7C,BDNFOS,BDNF, KIF18A,METT5D1,KCNA4,FSHB,C11orf46,MPPED2,DCDC1,DNAJC24,IMMP1L,ELP4,PAX6,RCN1,WT1,WIT1,EIF3M,CCDC73,PRRG4, QSER1,DEPDC7,TCP11L1,CSTF3,HIPK3,C11orf41,CD59,FBXO3,LMO2,CAPRIN1,NAT10,ABTB2,CAT,ELF5,EHF,APIP,PDHX,CD44, SLC1A2,DKFZP586H2123,FJX1 Del 11 36115488 36662689 547202 0.075 9.1 7 LDLRAD3,COMMD9,FLJ14213,TRAF6,RAG1,RAG2,C11orf74 Amp 12 56084979 56106676 21698 0.056 20 0 [Nearest:INHBC] Amp 12 56135099 61001541 96587 4.0E-117 94.5 1 CTDSP2 Amp 12 56135099 61001541 4866443 4.0E-117 94.5 29 INHBE,GLI1,ARHGAP9,MARS,DDIT3,MBD6,DCTN2,KIF5A,PIP4K2C,DTX3,GEFT,SLC26A10,B4GALNT1,OS9,AGAP2,TSPAN31, CDK4,9-Mar,CYP27B1,METTL1,FAM119B,TSFM,AVIL,CTDSP2,XRCC6BP1,LRIG3,SLC16A7,FAM19A2,USP15 Amp 12 61035406 61054010 18605 0.043 18.2 1 USP15 Amp 12 61108058 61186965 78908 0.015 18.2 1 MON2 Amp 12 61652819 61661575 8757 0.083 18.2 0 [Nearest:PPM1H] Amp 12 62731258 63181490 450233 5.4E-08 40 5 SRGAP1,C12orf66,C12orf56,XPOT,TBK1 Amp 12 63267869 63346598 78730 0.010 20 1 RASSF3 Amp 12 63382272 78071183 190700 9.4E-61 52.7 1 HMGA2 Amp 12 63382272 78071183 51891 4.4E-133 98.2 1 CPM Amp 12 63382272 78071183 14688912 4.4E-133 98.2 58 GNS,WIF1,LEMD3,MSRB3,HMGA2,LLPH,TMBIM4,IRAK3,HELB,GRIP1,CAND1,DYRK2,IFNG,IL26,IL22,MDM1,RAP1B,hCG_1757335, NUP107,SLC35E3,MDM2,CPM,CPSF6,LYZ,YEATS4,FRS2,CCT2,LRRC10,BEST3,RAB3IP,CNOT2,KCNMB4, PTPRB,PTPRR,TSPAN8,LGR5,ZFC3H1,THAP2,TMEM19,RAB21,TBC1D15,TPH2,TRHDE,KCNC2,CAPS2,GLIPR1L1, GLIPR1L2,GLIPR1,KRR1,PHLDA1,NAP1L1,BBS10,OSBPL8,ZDHHC17,CSRP2,E2F7,NAV3,SYT1 Amp 12 78101964 78132029 30066 0.086 20 1 SYT1 Amp 12 78214100 78233561 19462 0.045 18.2 1 SYT1 Amp 12 78306130 78481096 174967 0.0022 23.6 1 SYT1 Amp 12 78615059 78632312 17254 0.082 20 0 [Nearest:PAWR] Amp
Load more

Recommended publications
  • Screening and Identification of Key Biomarkers in Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Screening and identification of key biomarkers in clear cell renal cell carcinoma based on bioinformatics analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Clear cell renal cell carcinoma (ccRCC) is one of the most common types of malignancy of the urinary system. The pathogenesis and effective diagnosis of ccRCC have become popular topics for research in the previous decade. In the current study, an integrated bioinformatics analysis was performed to identify core genes associated in ccRCC. An expression dataset (GSE105261) was downloaded from the Gene Expression Omnibus database, and included 26 ccRCC and 9 normal kideny samples. Assessment of the microarray dataset led to the recognition of differentially expressed genes (DEGs), which was subsequently used for pathway and gene ontology (GO) enrichment analysis.
    [Show full text]
  • Human CD64 / FCGR1A Protein (His Tag), Biotinylated
    Human CD64 / FCGR1A Protein (His Tag), Biotinylated Catalog Number: 10256-H08S-B General Information SDS-PAGE: Gene Name Synonym: CD64; Fc gamma RI Protein Construction: A DNA sequence encoding the human FCGR1A (NP_000557.1) (Met1- Pro288) was expressed with a polyhistidine tag at the C-terminus. The purified protein was biotinylated in vitro. Source: Human Expression Host: CHO Stable Cells QC Testing Purity: > 95 % as determined by SDS-PAGE. Bio Activity： Protein Description Measured by its binding ability in a functional ELISA.Immobilized High affinity immunoglobulin gamma Fc receptor I, also known as FCGR1 biotinylated Human CD64 Protein (Cat：10256-H08S-B)at 10 μg/mL can and CD64, is an integral membraneglycoprotein and a member of the bind human IgG1,The EC50 of human IgG1 is 6-14 ng/mL. immunoglobulin superfamily. CD64 is a high affinity receptor for the Fc region of IgG gamma and functions in both innate and adaptive immune Endotoxin: responses. Receptors that recognize the Fc portion of IgG function in the regulation of immune response and are divided into three classes < 1.0 EU per μg protein as determined by the LAL method. designated CD64, CD32, and CD16. CD64 is structurally composed of asignal peptidethat allows its transport to the surface of a cell, Stability: threeextracellularimmunoglobulin domainsof the C2-type that it uses to Samples are stable for up to twelve months from date of receipt at -70 ℃ bind antibody, a hydrophobictransmembrane domain, and a short cytoplasmic tail. CD64 isconstitutivelyfound on only macrophages and Predicted N terminal: Gln 16 monocytes, but treatment of polymorphonuclear leukocyteswith cytokines likeIFNγandG-CSFcan induce CD64 expression on these cells.
    [Show full text]
  • 1 Evidence for Gliadin Antibodies As Causative Agents in Schizophrenia
    1 Evidence for gliadin antibodies as causative agents in schizophrenia. C.J.Carter PolygenicPathways, 20 Upper Maze Hill, Saint-Leonard’s on Sea, East Sussex, TN37 0LG [email protected] Tel: 0044 (0)1424 422201 I have no fax Abstract Antibodies to gliadin, a component of gluten, have frequently been reported in schizophrenia patients, and in some cases remission has been noted following the instigation of a gluten free diet. Gliadin is a highly immunogenic protein, and B cell epitopes along its entire immunogenic length are homologous to the products of numerous proteins relevant to schizophrenia (p = 0.012 to 3e-25). These include members of the DISC1 interactome, of glutamate, dopamine and neuregulin signalling networks, and of pathways involved in plasticity, dendritic growth or myelination. Antibodies to gliadin are likely to cross react with these key proteins, as has already been observed with synapsin 1 and calreticulin. Gliadin may thus be a causative agent in schizophrenia, under certain genetic and immunological conditions, producing its effects via antibody mediated knockdown of multiple proteins relevant to the disease process. Because of such homology, an autoimmune response may be sustained by the human antigens that resemble gliadin itself, a scenario supported by many reports of immune activation both in the brain and in lymphocytes in schizophrenia. Gluten free diets and removal of such antibodies may be of therapeutic benefit in certain cases of schizophrenia. 2 Introduction A number of studies from China, Norway, and the USA have reported the presence of gliadin antibodies in schizophrenia 1-5. Gliadin is a component of gluten, intolerance to which is implicated in coeliac disease 6.
    [Show full text]
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • Table 2. Significant
    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Clinical Vignette Novel Bi-Allelic Variants in GJC2 Associated
    Clinical Vignette Novel Bi-allelic Variants in GJC2 Associated Pelizaeus- Merzbacher-like Disease 1: Clinical Clues and Differential Diagnosis Veronica Arora, Sapna Sandal, Ishwar Verma Institute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi Correspondence to: Dr Ishwar C Verma Email: [email protected] Abstract the environment and did not follow objects. Head titubation was present. There was no facial dys- Hypomyelinating Leukodystrophy-2 (HLD2) or morphism. Anthropometric measurements were Pelizaeus-Merzbacher-like disease 1 (PMLD1) is a as follows: length 82cm (+1.2SD), weight 10.6Kg slowly progressive leukodystrophy characterized (+1.1SD) and head circumference 47.7cm (+1.2SD). by nystagmus, hypotonia, and developmental Central nervous system examination showed bilat- delay. It is a close differential diagnosis for eral pendular nystagmus, axial hypotonia, dystonic Pelizaeus- Merzbacher disease (PMD) and should posturing, and choreo-athetoid movements (Figure be suspected in patients with features of PMD but 1). Deep tendon reflexes were brisk with extensor who are negative on testing for duplication of the plantar responses. The rest of the systemic PLP1 gene. We describe a case of a 16-month-old examination was non-contributory. MRI of the boy with a novel homozygous mutation in the GJC2 brain (axial view) showed diffuse hypo-myelination gene resulting in hypomyelinating leukodystrophy- in the peri-ventricular and sub-cortical area and 2. The clinical clues as well as features of other cerebellar white matter changes (Figure 2). disorders presenting similarly are discussed. Given the presence of hypotonia, brisk reflexes, nystagmus and hypomyelination on MRI, a deletion Clinical description duplication analysis for the PLP1 gene was done which was negative.
    [Show full text]
  • Supplemental Materials ZNF281 Enhances Cardiac Reprogramming
    Supplemental Materials ZNF281 enhances cardiac reprogramming by modulating cardiac and inflammatory gene expression Huanyu Zhou, Maria Gabriela Morales, Hisayuki Hashimoto, Matthew E. Dickson, Kunhua Song, Wenduo Ye, Min S. Kim, Hanspeter Niederstrasser, Zhaoning Wang, Beibei Chen, Bruce A. Posner, Rhonda Bassel-Duby and Eric N. Olson Supplemental Table 1; related to Figure 1. Supplemental Table 2; related to Figure 1. Supplemental Table 3; related to the “quantitative mRNA measurement” in Materials and Methods section. Supplemental Table 4; related to the “ChIP-seq, gene ontology and pathway analysis” and “RNA-seq” and gene ontology analysis” in Materials and Methods section. Supplemental Figure S1; related to Figure 1. Supplemental Figure S2; related to Figure 2. Supplemental Figure S3; related to Figure 3. Supplemental Figure S4; related to Figure 4. Supplemental Figure S5; related to Figure 6. Supplemental Table S1. Genes included in human retroviral ORF cDNA library. Gene Gene Gene Gene Gene Gene Gene Gene Symbol Symbol Symbol Symbol Symbol Symbol Symbol Symbol AATF BMP8A CEBPE CTNNB1 ESR2 GDF3 HOXA5 IL17D ADIPOQ BRPF1 CEBPG CUX1 ESRRA GDF6 HOXA6 IL17F ADNP BRPF3 CERS1 CX3CL1 ETS1 GIN1 HOXA7 IL18 AEBP1 BUD31 CERS2 CXCL10 ETS2 GLIS3 HOXB1 IL19 AFF4 C17ORF77 CERS4 CXCL11 ETV3 GMEB1 HOXB13 IL1A AHR C1QTNF4 CFL2 CXCL12 ETV7 GPBP1 HOXB5 IL1B AIMP1 C21ORF66 CHIA CXCL13 FAM3B GPER HOXB6 IL1F3 ALS2CR8 CBFA2T2 CIR1 CXCL14 FAM3D GPI HOXB7 IL1F5 ALX1 CBFA2T3 CITED1 CXCL16 FASLG GREM1 HOXB9 IL1F6 ARGFX CBFB CITED2 CXCL3 FBLN1 GREM2 HOXC4 IL1F7
    [Show full text]
  • FCGR1A Recombinant Protein
    FCGR1A Recombinant Protein CATALOG NUMBER: 96-305 The purity of rh CD64 / FCGR1A was determined by DTT-reduced (+) SDS- PAGE and staining overnight with Coomassie Blue. Specifications SPECIES: Human SOURCE SPECIES: HEK293 cells SEQUENCE: Gln 16 - Pro 288 FUSION TAG: His Tag TESTED APPLICATIONS: WB APPLICATIONS: This recombinant protein can be used for WB. For research use only. BIOLOGICAL ACTIVITY: Measured by its ability to bind human IgG1 in the SPR assay (Biacore 2000) with the KD < 5 nM. Measured by its binding ability in a functional ELISA. Immobilized Human IgG4 at 10ug/mL (100 µl/well),can bind Human Fc gamma RI, His Tag (Cat# FCA-H52H2) with a linear of 0.1-2 ng/mL. Properties PURITY: >90% as determined by SDS-PAGE. PREDICTED MOLECULAR 32.5 kDa WEIGHT: PHYSICAL STATE: Lyopholized BUFFER: PBS, pH7.4 STORAGE CONDITIONS: Lyophilized Protein should be stored at -20˚C or lower for long term storage. Upon reconstitution, working aliquots should be stored at -20˚C or -70˚C. Avoid repeated freeze-thaw cycles. Additional Info ALTERNATE NAMES: FCGR1A, FCG1, FCGR1, IGFR1, CD64, CD64A, FCRI ACCESSION NO.: AAH32634 Background Receptors that recognize the Fc portion of IgG are divided into three groups designated Fc gamma RI, RII, and RIII, also known respectively as CD64, CD32, and CD16. Fc gamma RI binds IgG with high affinity and functions during early immune responses. Fc gamma RII and RIII are low affinity receptors that recognize IgG as aggregates surrounding multivalent antigens during late immune responses. High affinity immunoglobulin gamma Fc receptor I is also known as FCGR1A, FCG1, FCGR1, CD64 and IGFR1, is a type of integral membrane glycoprotein that binds monomeric IgG-type antibodies with high affinity, which belongs to the immunoglobulin superfamily or FCGR1 family.
    [Show full text]
  • Cd1a [O10] Concentrated and Prediluted Monoclonal Antibody 901-3158-061719
    CD1a [O10] Concentrated and Prediluted Monoclonal Antibody 901-3158-061719 Catalog Number: ACI 3158 A, B API 3158 AA VLTM 3158 G20 Description: 0.1, 0.5 mL conc. 6.0 mL, RTU 20 mL, RTU Dilution: 1:100 Ready-to-use Ready-to-use Diluent: Van Gogh Yellow N/A N/A Intended Use: Protocol Recommendations (VALENT® Automated Slide For In Vitro Diagnostic Use Staining Platform) Cont’d: CD1a [O10] is a mouse monoclonal antibody that is intended for Protein Block (Optional): Incubate for 10-20 minutes at RT with Val laboratory use in the qualitative identification of CD1a protein by Background Block. immunohistochemistry (IHC) in formalin-fixed paraffin-embedded Primary Antibody: Incubate for 30 minutes. (FFPE) human tissues. The clinical interpretation of any staining or its Secondary: Incubate for 10 minutes with Val Mouse Secondary. absence should be complemented by morphological studies using proper Linker: Incubate for 10 minutes with Val Universal Linker. controls and should be evaluated within the context of the patient’s Polymer: Incubate for 10 minutes with Val Universal Polymer. clinical history and other diagnostic tests by a qualified pathologist. Chromogen: Incubate for 5 minutes with Val DAB. Summary and Explanation: Counterstain: Counterstain for 5 minutes with Val Hematoxylin. CD1a is a protein of 43 to 49 kDa and is expressed on dendritic cells and cortical thymocytes (1,2). CD1a [O10] staining has been shown to be Protocol Recommendations (intelliPATH FLX® and manual use): useful in the differentiation of Langerhans cells from interdigitating cells. Peroxide Block: Block for 5 minutes with Peroxidazed 1. It has also proved useful for phenotyping Langerhans cell histiocytosis Pretreatment: Perform heat retrieval using Diva or Reveal Decloaker.
    [Show full text]
  • 9. Atypical Dusps: 19 Phosphatases in Search of a Role
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Digital.CSIC Transworld Research Network 37/661 (2), Fort P.O. Trivandrum-695 023 Kerala, India Emerging Signaling Pathways in Tumor Biology, 2010: 185-208 ISBN: 978-81-7895-477-6 Editor: Pedro A. Lazo 9. Atypical DUSPs: 19 phosphatases in search of a role Yolanda Bayón and Andrés Alonso Instituto de Biología y Genética Molecular, CSIC-Universidad de Valladolid c/ Sanz y Forés s/n, 47003 Valladolid, Spain Abstract. Atypical Dual Specificity Phosphatases (A-DUSPs) are a group of 19 phosphatases poorly characterized. They are included among the Class I Cys-based PTPs and contain the active site motif HCXXGXXR conserved in the Class I PTPs. These enzymes present a phosphatase domain similar to MKPs, but lack any substrate targeting domain similar to the CH2 present in this group. Although most of these phosphatases have no more than 250 amino acids, their size ranges from the 150 residues of the smallest A-DUSP, VHZ/DUSP23, to the 1158 residues of the putative PTP DUSP27. The substrates of this family include MAPK, but, in general terms, it does not look that MAPK are the general substrates for the whole group. In fact, other substrates have been described for some of these phosphatases, like the 5’CAP structure of mRNA, glycogen, or STATs and still the substrates of many A-DUSPs have not been identified. In addition to the PTP domain, most of these enzymes present no additional recognizable domains in their sequence, with the exception of CBM-20 in laforin, GTase in HCE1 and a Zn binding domain in DUSP12.
    [Show full text]
  • Single-Cell RNA Sequencing Demonstrates the Molecular and Cellular Reprogramming of Metastatic Lung Adenocarcinoma
    ARTICLE https://doi.org/10.1038/s41467-020-16164-1 OPEN Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma Nayoung Kim 1,2,3,13, Hong Kwan Kim4,13, Kyungjong Lee 5,13, Yourae Hong 1,6, Jong Ho Cho4, Jung Won Choi7, Jung-Il Lee7, Yeon-Lim Suh8,BoMiKu9, Hye Hyeon Eum 1,2,3, Soyean Choi 1, Yoon-La Choi6,10,11, Je-Gun Joung1, Woong-Yang Park 1,2,6, Hyun Ae Jung12, Jong-Mu Sun12, Se-Hoon Lee12, ✉ ✉ Jin Seok Ahn12, Keunchil Park12, Myung-Ju Ahn 12 & Hae-Ock Lee 1,2,3,6 1234567890():,; Advanced metastatic cancer poses utmost clinical challenges and may present molecular and cellular features distinct from an early-stage cancer. Herein, we present single-cell tran- scriptome profiling of metastatic lung adenocarcinoma, the most prevalent histological lung cancer type diagnosed at stage IV in over 40% of all cases. From 208,506 cells populating the normal tissues or early to metastatic stage cancer in 44 patients, we identify a cancer cell subtype deviating from the normal differentiation trajectory and dominating the metastatic stage. In all stages, the stromal and immune cell dynamics reveal ontological and functional changes that create a pro-tumoral and immunosuppressive microenvironment. Normal resident myeloid cell populations are gradually replaced with monocyte-derived macrophages and dendritic cells, along with T-cell exhaustion. This extensive single-cell analysis enhances our understanding of molecular and cellular dynamics in metastatic lung cancer and reveals potential diagnostic and therapeutic targets in cancer-microenvironment interactions. 1 Samsung Genome Institute, Samsung Medical Center, Seoul 06351, Korea.
    [Show full text]